Tactile Systems Technology, Inc. (TCMD) has a MoatMap StockRank of 89/100 based on Quality (76/100), Value (46/100), and Momentum (53/100) factor scores. The current signal is STRONG BUY. Tactile Systems Technology is a medical device company with solid quality metrics (Q: 76) but lacks any structural alignment with our 18-month macro themes, making it unsuitable for this high-conviction portfolio.
Tactile Systems Technology, Inc. develops and commercializes medical devices for the treatment of chronic conditions such as lymphedema and chronic venous insufficiency. The company's proprietary Flexitouch Plus and other pneumatic compression devices establish a strong market position by offering clinically proven, non-invasive solutions that improve patient outcomes. Tactile Systems operates as a specialized medical technology innovator with a direct-to-patient service model.
| Price | $26.34 |
| Market Cap | $576M |
| P/E (TTM) | 28.93 |
| P/E (Forward) | 16.72 |
| Price/Book | 2.62 |
| Return on Equity | 9.6% |
| Return on Invested Capital | 13.9% |
| Debt/Equity | 6.96 |
| Gross Margin | 76.4% |
| Operating Margin | -2.0% |
| Revenue Growth | 22.8% |
| Free Cash Flow | $33M |
Tactile Systems Technology, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).